Apex Biotechnology (TPE:1733) E10: NT$1.28 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1733 Apex Biotechnology Corp TPE:1733
78 GF Score
Price NT$32.25
GF Value NT$30.05
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Apex Biotechnology E10?

Apex Biotechnology TPE:1733 +0.47% 78 E10 is NT$1.28 as of Jun. 2026. GuruFocus rates TPE:1733 with a GF Score™ of 78/100 and a GF Value™ of NT$30.05 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Apex Biotechnology's adjusted earnings per share data for the three months ended in Jun. 2026 was NT$0.370. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$1.28 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Apex Biotechnology's average E10 Growth Rate was -12.90% per year. During the past 3 years, the average E10 Growth Rate was -12.40% per year. During the past 5 years, the average E10 Growth Rate was -13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Apex Biotechnology was -12.40% per year. The lowest was -14.20% per year. And the median was -13.95% per year.

As of today (2026-08-23), Apex Biotechnology's current stock price is NT$32.25. Apex Biotechnology's E10 for the quarter that ended in Jun. 2026 was NT$1.28. Apex Biotechnology's Shiller PE Ratio of today is 25.20.

During the past 13 years, the highest Shiller PE Ratio of Apex Biotechnology was 26.59. The lowest was 6.25. And the median was 13.62.


Apex Biotechnology  (TPE:1733) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Apex Biotechnology's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=32.25/1.28
=25.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Apex Biotechnology was 26.59. The lowest was 6.25. And the median was 13.62.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Apex Biotechnology E10 Related Terms


Apex Biotechnology E10 Historical Data

* Premium members only.

The historical data trend for Apex Biotechnology's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apex Biotechnology E10 Chart

Apex Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.28 1.92 1.63 1.45 1.29

Apex Biotechnology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.47 1.35 1.29 1.31 1.28

TPE:1733 vs VRTX, REGN, RVMD: E10 Comparison

For the Biotechnology subindustry, Apex Biotechnology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Biotechnology Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's Shiller PE Ratio falls into.


TPE:1733
78GF Score
Apex Biotechnology Corp TPE:1733
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apex Biotechnology E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Apex Biotechnology's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.37/333.9520*333.9520
=0.370

Current CPI (Jun. 2026) = 333.9520.

Apex Biotechnology Quarterly Data

per share eps CPI Adj_EPS
201609 0.010 241.428 0.014
201612 -1.310 241.432 -1.812
201703 -0.390 243.801 -0.534
201706 0.550 244.955 0.750
201709 0.220 246.819 0.298
201712 0.440 246.524 0.596
201803 0.170 249.554 0.227
201806 0.410 251.989 0.543
201809 0.630 252.439 0.833
201812 -0.380 251.233 -0.505
201903 0.200 254.202 0.263
201906 0.260 256.143 0.339
201909 -0.170 256.759 -0.221
201912 0.720 256.974 0.936
202003 0.110 258.115 0.142
202006 0.250 257.797 0.324
202009 0.210 260.280 0.269
202012 0.300 260.474 0.385
202103 0.310 264.877 0.391
202106 0.210 271.696 0.258
202109 0.640 274.310 0.779
202112 0.790 278.802 0.946
202203 0.450 287.504 0.523
202206 0.290 296.311 0.327
202209 0.640 296.808 0.720
202212 0.430 296.797 0.484
202303 0.360 301.836 0.398
202306 0.270 305.109 0.296
202309 0.380 307.789 0.412
202312 0.150 306.746 0.163
202403 0.290 312.332 0.310
202406 0.270 314.175 0.287
202409 0.330 315.301 0.350
202412 0.380 315.605 0.402
202503 0.620 319.799 0.647
202506 0.287 322.561 0.297
202509 0.220 324.800 0.226
202512 0.500 324.054 0.515
202603 0.810 330.213 0.819
202606 0.370 333.952 0.370

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$1.28 mean?
Apex Biotechnology (TPE:1733) has a E10 of NT$1.28 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Apex Biotechnology and its competitors.
Is Apex Biotechnology's E10 too high?
Apex Biotechnology's current E10 is NT$1.28. Overall, Apex Biotechnology has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apex Biotechnology's E10 compare to VRTX and REGN?
Apex Biotechnology's E10 of NT$1.28 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Apex Biotechnology and its competitors. Apex Biotechnology's current E10 is NT$1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Apex Biotechnology (TPE:1733) is currently considered Fairly Valued. The stock's GF Value™ is NT$30.05, compared to a current price of NT$32.25 — trading 7.3% above its estimated fair value. The current E10 is NT$1.28. Apex Biotechnology's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Apex Biotechnology (TPE:1733), the current E10 is NT$1.28 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apex Biotechnology (TPE:1733) Overvalued in 2026?

Based on GuruFocus' analysis, Apex Biotechnology stock appears to be overvalued. The current stock price of NT$32.25 is trading 7.3% above its estimated GF Value™ of NT$30.05. GuruFocus considers Apex Biotechnology to be Fairly Valued.

Key valuation signals for TPE:1733:

  • E10: NT$1.28
  • GF Value™: NT$30.05 vs. price of NT$32.25 (7.3% above fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the TPE:1733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Apex Biotechnology Business Description

Address Li-Hsin 5th Road, No. 7, Hsinchu Science Park, Hsinchu, TWN, 30078
Apex Biotechnology Corp is engaged in the research, development, production, manufacturing, and sale of biochemical testing instruments and proprietary test strips, as well as the import and export of products and components related to its core business. Its product offerings include diabetes testing kits, blood uric acid monitoring systems, blood lactate monitoring systems, blood haemoglobin monitoring systems, etc. The company generates maximum revenue from the sale of test strips, and the rest from testing meters, electrodes, and other products. Geographically, it derives maximum revenue from the USA, and the rest from Italy, Austria, Taiwan, China, and other markets.
78GF Score

Get the complete analysis for TPE:1733

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.25
Price
NT$30.05
GF Value